Almujtama Alraida Medical Co. (9592.SR) — Cash flow
Operating, investing, and financing cash flow for Almujtama Alraida Medical Co. — annual and quarterly.
| Metric (SAR Millions) | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 8 | 0.00↓100.0% | 21↑154.6% | 8 | |
| Depreciation & Amortization | 41 | 0.00↓100.0% | 22↓7.3% | 24 | |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes in Working Capital | -6↓130.4% | 21↑166.2% | -32↓78.9% | -18 | |
| Accounts Receivable | -9↑19.9% | -12↓1537.9% | 0.82↑106.6% | -12 | |
| Inventory | -5↓6.3% | -4↑51.5% | -9↑70.0% | -29 | |
| Accounts Payable | 12↓60.0% | 30↑221.4% | -25↓168.1% | 36 | |
| Other Working Capital | -4↓160.3% | 7↑942.2% | 0.70↑105.7% | -12 | |
| Other Non-Cash Items | 9↓81.6% | 47↑538.9% | 7↑138.7% | 3 | |
| Net Cash from Operating Activities | 51↓24.6% | 68↑267.6% | 19↑7.3% | 17 | |
| Operating Cash Flow | 51↓24.6% | 68↑267.6% | 19↑7.3% | 17 | |
| Investing Activities | |||||
| Investment in Property, Plant & Equipment | -28↑30.2% | -40↓106.3% | -20↓167.2% | -7 | |
| Capital Expenditure | -28↑30.2% | -40↓106.3% | -20↓167.2% | -7 | |
| Acquisitions | 0.19↑89.4% | 0.10 | 0.00 | 0.00 | |
| Purchases of Investments | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales & Maturities of Investments | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Cash from Investing Activities | -28↑30.5% | -40↓105.8% | -20↓167.2% | -7 | |
| Financing Activities | |||||
| Net Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-Term Net Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | |
| Short-Term Net Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Buybacks | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Preferred Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -34↓80.8% | -19↓2253.0% | 0.88↑108.9% | -10 | |
| Net Cash from Financing Activities | -34↓80.8% | -19↓2253.0% | 0.88↑108.9% | -10 | |
| Cash Reconciliation | |||||
| Effect of Foreign Exchange | 0.00 | 0.00 | 0.00↓100.0% | 4 | |
| Net Change in Cash | -11↓221.0% | 9↑5598.4% | -0.16↓103.9% | 4 | |
| Cash at Beginning of Period | 13↑220.6% | 4↓3.9% | 4↑106.5% | 2 | |
| Cash at End of Period | 2↓83.2% | 13↑220.6% | 4↓3.9% | 4 | |
| Income Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | 23↓16.6% | 28↑2766.3% | -1↓110.5% | 10 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.